Katrine H. Thorhauge (@khthorhauge) 's Twitter Profile
Katrine H. Thorhauge

@khthorhauge

ID: 1340903799779692544

calendar_today21-12-2020 06:16:03

60 Tweet

83 Followers

103 Following

Mads Israelsen (@israelsenmads) 's Twitter Profile Photo

Alcohol & Steatotic Liver Disease Embracing the new nomenclature? YES🤗 - less stigma🙅‍♂️🙅‍♀️ - more precise profiling🩺📊 - opportunities for better care🏥💊 BUT🤔 Very different prognosis between MASLD, MetALD, and ALD Read our view in The Lancet Gastroenterology & Hepatology bit.ly/3qlpWfL

Alcohol & Steatotic Liver Disease

Embracing the new nomenclature?

YES🤗

- less stigma🙅‍♂️🙅‍♀️
- more precise profiling🩺📊
- opportunities for better care🏥💊

BUT🤔

Very different prognosis between MASLD, MetALD, and ALD

Read our view in <a href="/LancetGastroHep/">The Lancet Gastroenterology & Hepatology</a>
bit.ly/3qlpWfL
Maja Thiele (@majathiele) 's Twitter Profile Photo

Are ALD and MASLD just part of the same spectrum? Yes & no says Mads Israelsen FLASH - Liver Research ✅Fibrogenic over decades ✅Steatotic 🚫Very different prognosis 🚫Histological subtleties (Study of Alcohol-related LiVer disease in Europe) 🚫Alc. hepatitis unparalleled by any MASLD #Livertwitter

Katrine H. Thorhauge (@khthorhauge) 's Twitter Profile Photo

Impressive work! Congrats Florian Rosenberger and co. 🎉 Very excited about our collab applying these cutting edge methods to gain mechanistic insight in alpha1-antitrypsin deficiency 🤩 Stay tuned 💣! FLASH - Liver Research Matthias Mann Lab

Stine Johansen (@stine_johansen_) 's Twitter Profile Photo

❗️ Infections = worse prognosis in early ALD❗️ Just published in JHEP Reports 🦠 Despite early stage ALD, high incidence of infections: 1/3 during 4.5 years 🦠 Infections: Risk of death 8 times up 🦠 Risk of decompensation 5 times up 🔗 jhep-reports.eu/article/S2589-…

❗️ Infections = worse prognosis in early ALD❗️

Just published in <a href="/JHEP_Reports/">JHEP Reports</a> 

🦠 Despite early stage ALD, high incidence of infections: 1/3 during 4.5 years
🦠 Infections: Risk of death 8 times up
🦠 Risk of decompensation 5 times up

🔗 jhep-reports.eu/article/S2589-…
Maja Thiele (@majathiele) 's Twitter Profile Photo

How to battle stigma towards alcohol & obesity? #LiverTwitter In our #narrativemedicine project we let go of the data and dived into patients' own narratives instead Animation of Hans and his story "You have been declared highly alcoholic and obese" youtu.be/hwcDhDKokpI

EASLnews (@easlnews) 's Twitter Profile Photo

Why does alpha-1-antitrypsin deficiency stand out as the prime candidate for gene therapy? Tune in tomorrow 18:00 CET for this new #EASLStudio episode and hear from experts Aleksander Krag, Aftab Ala, Pavel Strnad and Alice Turner. 📺easl.eu/easl-studio-ep… #LiverTwitter

Aleksander Krag (@aleksanderkrag) 's Twitter Profile Photo

Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease Check out👉- Journal of Hepatology 👉How to use and interpret repeated Fibroscan journal-of-hepatology.eu/article/S0168-… Katrine H. Thorhauge @GeorgSemmler

Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease 
Check out👉- Journal of Hepatology 
👉How to use and interpret repeated Fibroscan
journal-of-hepatology.eu/article/S0168-…
<a href="/KHThorhauge/">Katrine H. Thorhauge</a> @GeorgSemmler
Journal of Hepatology (@jhepatology) 's Twitter Profile Photo

🆕Article in press❕ Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease #OpenAccess here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

🆕Article in press❕ 

Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease

#OpenAccess here👉journal-of-hepatology.eu/article/S0168-…

#LiverTwitter
Maja Thiele (@majathiele) 's Twitter Profile Photo

I am so proud of the first results coming out from FLASH - Liver Research DECIDE & LiverScreen H2020 cohort. It all started with an idea, protocol and first patient in 2017, supported by #Horizon2020 Novo Nordisk Foundation funding Now: Mads Israelsen summing up at the big stage #EASLcongress

I am so proud of the first results coming out from <a href="/FLASH_OUH/">FLASH - Liver Research</a> DECIDE &amp; <a href="/Liver_Screen/">LiverScreen H2020</a> cohort.

It all started with an idea, protocol and first patient in 2017, supported by #Horizon2020
<a href="/novonordiskfond/">Novo Nordisk Foundation</a> funding

Now: <a href="/IsraelsenMads/">Mads Israelsen</a> summing up at the big stage #EASLcongress
Aleksander Krag (@aleksanderkrag) 's Twitter Profile Photo

Meet LiverPro - a novel digital automated tool to assess risk of fibrosis in the population and primary care ⁃First CE approved tool👉ready for clinical use ⁃Let’s improve care pathways in SLD 🤩@KatrinePLindvig Today in The Lancet Gastroenterology & Hepatology sciencedirect.com/science/articl…

Meet LiverPro - a novel digital automated tool to assess risk of fibrosis in the population and primary care 

⁃First CE approved tool👉ready for clinical use 
⁃Let’s improve care pathways in SLD

🤩@KatrinePLindvig 

Today in <a href="/LancetGastroHep/">The Lancet Gastroenterology & Hepatology</a> 

sciencedirect.com/science/articl…
Aleksander Krag (@aleksanderkrag) 's Twitter Profile Photo

Why do some patients remain healthy while others develop severe liver complications despite having the exact same genetic mutation in Alpha-1 Antitrypsin Deficiency?   Proud 😊- Deep Visual Proteomics at single cell level 👉in nature   nature.com/articles/s4158…   Matthias Mann Lab

Why do some patients remain healthy while others develop severe liver complications despite having the exact same genetic mutation in Alpha-1 Antitrypsin Deficiency?
 
Proud 😊- Deep Visual Proteomics at single cell level 
👉in <a href="/Nature/">nature</a> 
 
nature.com/articles/s4158…
 
<a href="/labs_mann/">Matthias Mann Lab</a>
Katrine H. Thorhauge (@khthorhauge) 's Twitter Profile Photo

Incredibly proud to have been part of this important collaboration on alpha1-antrypsin deficiency and liver ❓Why does some get sick - others not? 🔬DVP to reveal responses and compensatory mechanisms 🎉 Published in nature

Max Planck Institute of Biochemistry (MPIB) (@mpi_biochem) 's Twitter Profile Photo

Scientists Matthias Mann Lab, at Pavel Strnad Lab Uniklinik RWTH AC & at Alksander Krag Lab OUH Odense Svendborg have used spatial #DeepVisualProteomics to reveal how liver cells become sick in patients with the proteotoxic disease alpha-1 antitrypsin deficiency. #AATD FLASH - Liver Research nature